Month:

September 2016

Mylan Medicaid Fraud Investigations

Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017   Mylan has already been under public scrutiny for increasing the price of its EpiPen allergy shots. Last week the State of West Virginia launched a Medicaid fraud investigation questioning Mylan’s price hike and compliance with drug rebate laws. Mylan Pharmaceuticals participates in …
Read more

CMS Issues Proposed Rule Addressing Multiple Fraud and Abuse Concerns

Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017   The Centers for Medicare and Medicaid Services (CMS) recently proposed a new rule in the Federal Register that addresses changes in Medicare payment policies. The proposed rule aims to inform providers of proper billing practices and prevent fraud and abuse.  This post …
Read more

Medicare Advantage Audits Reveal Alleged Rampant Upcoding

Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017   Last month, the Center for Public Integrity obtained over three-dozen new Medicare Advantage (MA) audits through a lawsuit brought under the Freedom of Information Act. The audits indicate that overcharging is still a pervasive problem in the MA Program because Medicare Advantage …
Read more

Medicare Regulations Compliance for Long-term Care Hospitals-within-Hospitals

Christine S. Kim Assistant Editor Loyola University Chicago School of Law, J.D. 2017   Due to the inextricably association between long-term care Hospitals-within-Hospitals (“HwHs”) and their respective Long Term Care Hospitals (“LTCH”), or host hospitals, efforts to circumvent compliance with federal reimbursement regulations have evolved. This blog article discusses the ways in which the Centers …
Read more

Compliance and The Dab

Ryan Whitney Managing Editor Loyola University School of Law, JD 2017   Dabbing has taken pop culture by storm in just the last year. Popularized by Carolina Panther’s quarterback Cam Newton, the dance move is now seen in all sorts of sports celebrations, dance adaptations, videos and promotions. It is a fad, a craze — …
Read more

Impaired and On the Clock: Developing Policies and Procedures to Cope with Impairment in the Workplace

Brittany Tomkies Executive Editor Loyola University Chicago School of Law, JD 2017   Drug and substance abuse has become an epidemic in the United States over the past 15 years, reaching an alarming 9.4% of Americans ages 12 and older in 2013. The human and economic costs of substance abuse are astonishing – some estimate …
Read more

19 Ingredients, 2.2 Million Pounds of Product and $368.7 Million to Comply

Brittany Tomkies Executive Editor Loyola University Chicago School of Law, JD 2017   The Food and Drug Administration (FDA) issued a final rule on September 2, 2016 establishing that certain over-the-counter (OTC) consumer antiseptic wash products (i.e. antibacterial hand and body soaps) containing certain active ingredients can no longer be marketed as they are not generally …
Read more

Another Suit against Vanguard Healthcare

Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017   In 2011, Vanguard Healthcare, LLC (“Vanguard”) settled a whistleblower suit for Medicare and Medicaid fraud and entered into a Corporate Integrity Agreement (CIA). Now the federal government is suing Vanguard for submitting fraudulent claims for services that were “either non-existent or grossly …
Read more

FTC Final Order against LabMD – The Intersection of Unfair Practices, Privacy, Security, and Compliance

Logan Parker Privacy Editor Loyola University Chicago School of Law, LL.M. in Health Law 2017   The Federal Trade Commission (“FTC”) issued an Opinion and Final Order on July 29, 2016 against LabMD, a now defunct medical testing laboratory, for its lax data security practices that constituted an unfair practice under Section 5 of the …
Read more

Big Pharma Scorecard Encouraging Greater Clinical Trial Transparency

Kaitlin Lavin Executive Editor Loyola University Chicago School of Law, JD 2017   Bioethics International (BEI), a non-profit organization, is working to improve transparency and ethics in healthcare delivery and innovation by holding pharmaceutical companies accountable for compliance with the Food and Drug Administration Amendments Act (FDAAA). Many people do not trust drug companies, believing …
Read more